Literature DB >> 24500260

MiR-15a-16 represses Cripto and inhibits NSCLC cell progression.

Feng Chen1, Shi-ke Hou, Hao-jun Fan, Ying-fu Liu.   

Abstract

MicroRNAs (miRNAs) are small noncoding RNAs that have important roles in cancer. The altered expressions of miRNAs and their target genes are frequently detected in various tumors. In this study, downregulation of miR-15a-16 in nonsmall cell lung cancer (NSCLC) was found to be inversely correlated with Cripto. Results from the Luciferase reporter assay and Western blot analysis also confirmed that Cripto is a direct target of miR-15a-16. In addition, transfection of miR-15a-16 expression plasmid inhibited the invasion ability and promoted the apoptosis of NCI-H23 and NCI-H358 cells. Moreover, miR-15a-16 overexpression suppressed tumor growth in vivo. These findings clearly suggest that the downregulation of miR-15a-16 with Cripto amplification may be involved in the development of NSCLC.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24500260     DOI: 10.1007/s11010-014-1981-y

Source DB:  PubMed          Journal:  Mol Cell Biochem        ISSN: 0300-8177            Impact factor:   3.396


  27 in total

1.  miR-20a promotes migration and invasion by regulating TNKS2 in human cervical cancer cells.

Authors:  Hong-Wei Kang; Fang Wang; Qian Wei; Yi-Fan Zhao; Min Liu; Xin Li; Hua Tang
Journal:  FEBS Lett       Date:  2012-02-22       Impact factor: 4.124

2.  Circulating miR-125b is a novel biomarker for screening non-small-cell lung cancer and predicts poor prognosis.

Authors:  Ma Yuxia; Tian Zhennan; Zhang Wei
Journal:  J Cancer Res Clin Oncol       Date:  2012-07-18       Impact factor: 4.553

Review 3.  Screening and early detection of lung cancer.

Authors:  Susan C Van't Westeinde; Rob J van Klaveren
Journal:  Cancer J       Date:  2011 Jan-Feb       Impact factor: 3.360

4.  The anti-metastatic activity of collagenase-2 in breast cancer cells is mediated by a signaling pathway involving decorin and miR-21.

Authors:  C Soria-Valles; A Gutiérrez-Fernández; M Guiu; B Mari; A Fueyo; R R Gomis; C López-Otín
Journal:  Oncogene       Date:  2013-07-15       Impact factor: 9.867

5.  Regulation of human Cripto-1 expression by nuclear receptors and DNA promoter methylation in human embryonal and breast cancer cells.

Authors:  Caterina Bianco; Nadia P Castro; Christina Baraty; Kelly Rollman; Natalie Held; Maria Cristina Rangel; Hideaki Karasawa; Monica Gonzales; Luigi Strizzi; David S Salomon
Journal:  J Cell Physiol       Date:  2013-06       Impact factor: 6.384

6.  Cripto-1 overexpression leads to enhanced invasiveness and resistance to anoikis in human MCF-7 breast cancer cells.

Authors:  Nicola Normanno; Antonella De Luca; Caterina Bianco; Monica R Maiello; Maria V Carriero; Aasia Rehman; Christian Wechselberger; Claudio Arra; Luigi Strizzi; Michele Sanicola; David S Salomon
Journal:  J Cell Physiol       Date:  2004-01       Impact factor: 6.384

7.  let-7b and miR-126 are down-regulated in tumor tissue and correlate with microvessel density and survival outcomes in non--small--cell lung cancer.

Authors:  Edin Jusufović; Matija Rijavec; Dragan Keser; Peter Korošec; Eva Sodja; Ermina Iljazović; Zorica Radojević; Mitja Košnik
Journal:  PLoS One       Date:  2012-09-24       Impact factor: 3.240

Review 8.  Role of miR-10b in breast cancer metastasis.

Authors:  Li Ma
Journal:  Breast Cancer Res       Date:  2010-10-26       Impact factor: 6.466

9.  miR-34a and miR-15a/16 are co-regulated in non-small cell lung cancer and control cell cycle progression in a synergistic and Rb-dependent manner.

Authors:  Nora Bandi; Erik Vassella
Journal:  Mol Cancer       Date:  2011-05-16       Impact factor: 27.401

10.  Suppression of cell growth and invasion by miR-205 in breast cancer.

Authors:  Hailong Wu; Shoumin Zhu; Yin-Yuan Mo
Journal:  Cell Res       Date:  2009-04       Impact factor: 25.617

View more
  12 in total

Review 1.  The multifaceted role of the embryonic gene Cripto-1 in cancer, stem cells and epithelial-mesenchymal transition.

Authors:  Malgorzata Klauzinska; Nadia P Castro; Maria Cristina Rangel; Benjamin T Spike; Peter C Gray; Daniel Bertolette; Frank Cuttitta; David Salomon
Journal:  Semin Cancer Biol       Date:  2014-08-19       Impact factor: 15.707

2.  miR-15a enhances the anticancer effects of cisplatin in the resistant non-small cell lung cancer cells.

Authors:  Vildan Bozok Çetintaş; Aslı Tetik Vardarlı; Zekeriya Düzgün; Burçin Tezcanlı Kaymaz; Eda Açıkgöz; Hüseyin Aktuğ; Buket Kosova Can; Cumhur Gündüz; Zuhal Eroğlu
Journal:  Tumour Biol       Date:  2015-08-28

3.  Midbrain dopamine neurons in Parkinson's disease exhibit a dysregulated miRNA and target-gene network.

Authors:  Christine E Briggs; Yulei Wang; Benjamin Kong; Tsung-Ung W Woo; Lakshmanan K Iyer; Kai C Sonntag
Journal:  Brain Res       Date:  2015-06-03       Impact factor: 3.252

4.  miR-16 induction after CDK4 knockdown is mediated by c-Myc suppression and inhibits cell growth as well as sensitizes nasopharyngeal carcinoma cells to chemotherapy.

Authors:  Qingping Jiang; Yajie Zhang; Mengyang Zhao; Qiulian Li; Ruichao Chen; Xiaobing Long; Weiyi Fang; Zhen Liu
Journal:  Tumour Biol       Date:  2015-09-17

5.  MicroRNA-133a downregulated EGFR expression in human non-small cell lung cancer cells via AKT/ERK signaling.

Authors:  Nannan Guo; Yingnan Zhao; Wen Zhang; Shaojun Li; Shanshan Li; Jianqi Yu
Journal:  Oncol Lett       Date:  2018-09-05       Impact factor: 2.967

6.  Cripto-1 as a novel therapeutic target for triple negative breast cancer.

Authors:  Nadia P Castro; Natalie D Fedorova-Abrams; Anand S Merchant; Maria Cristina Rangel; Tadahiro Nagaoka; Hideaki Karasawa; Malgorzata Klauzinska; Stephen M Hewitt; Kajal Biswas; Shyam K Sharan; David S Salomon
Journal:  Oncotarget       Date:  2015-05-20

Review 7.  Epithelial Plasticity in Cancer: Unmasking a MicroRNA Network for TGF-β-, Notch-, and Wnt-Mediated EMT.

Authors:  Eugenio Zoni; Gabri van der Pluijm; Peter C Gray; Marianna Kruithof-de Julio
Journal:  J Oncol       Date:  2015-03-25       Impact factor: 4.375

8.  Genetic variants modulating CRIPTO serum levels identified by genome-wide association study in Cilento isolates.

Authors:  Daniela Ruggiero; Stefania Nappo; Teresa Nutile; Rossella Sorice; Francesco Talotta; Emilia Giorgio; Celine Bellenguez; Anne-Louise Leutenegger; Giovanna L Liguori; Marina Ciullo
Journal:  PLoS Genet       Date:  2015-01-28       Impact factor: 5.917

Review 9.  Therapeutic use of microRNAs in lung cancer.

Authors:  Orazio Fortunato; Mattia Boeri; Carla Verri; Massimo Moro; Gabriella Sozzi
Journal:  Biomed Res Int       Date:  2014-09-16       Impact factor: 3.411

10.  CDK4 and miR-15a comprise an abnormal automodulatory feedback loop stimulating the pathogenesis and inducing chemotherapy resistance in nasopharyngeal carcinoma.

Authors:  Zhen Liu; Chao Cheng; Xiaojun Luo; Qiong Xia; Yejie Zhang; Xiaobing Long; Qingping Jiang; Weiyi Fang
Journal:  BMC Cancer       Date:  2016-03-18       Impact factor: 4.430

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.